Journal Article
Massumi, M., Pourasgari, F., Nalla, A., Batchuluun, B., Nagy, K., Neely, E., Gull, R., Nagy, A., and Wheeler, M.B. (2016). An Abbreviated Protocol for In Vitro Generation of Functional Human Embryonic Stem Cell-Derived Beta-Like Cells.Plos One11, e0164457.
Rama, A.R., Alvarez, P.J., Madeddu, R., and Aránega, A. (2014). ABC transporters as differentiation markers in glioblastoma cells.Mol Biol Rep.
Coyle, B., Kessler, M., Sabnis, D.H., and Kerr, I.D. (2015). ABCB1 in children's brain tumours.Biochem Soc Trans43, 1018-1022.
Louphrasitthiphol, P., Chauhan, J., and Goding, C.R. (2019). ABCB5 is activated by MITF andβ-catenin and is associated with melanoma differentiation.Pigment Cell Melanoma Res.
Chen, Y.-H., Cimino, P.J., Luo, J., Dahiya, S., and Gutmann, D.H. (2016). ABCG1 maintains high-grade glioma survival in vitro and in vivo.Oncotarget.
Leccia, F., Del Vecchio, L., Mariotti, E., Di Noto, R., Morel, A.-P., Puisieux, A., Salvatore, F., and Ansieau, S. (2014). ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells.Mol Cancer13, 213.
Damiani, D., Tiribelli, M., Geromin, A., Cerno, M., Zanini, F., Michelutti, A., and Fanin, R. (2016). ABCG2, Cytogenetic and Age Predict Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission.Biol Blood Marrow Transplant.
Kawai, N., Hirohashi, Y., Ebihara, Y., Saito, T., Murai, A., Saito, T., Shirosaki, T., Kubo, T., Nakatsugawa, M., Kanaseki, T., et al. (2019). ABCG2 expression is related to low 5-ALA photodynamic diagnosis (PDD) efficacy and cancer stem cell phenotype, and suppression of ABCG2 improves the efficacy of PDD.Plos One14, e0216503.
Szepesi, A., Matula, Z., Szigeti, A., Várady, G., Szabó, G., Uher, F., Sarkadi, B., and Német, K. (2014). ABCG2 is a selectable marker for enhanced multilineage differentiation potential in periodontal ligament stem cells.Stem Cells Dev.
Ling, X., Wu, W., Fan, C., Xu, C., Liao, J., Rich, L.J., Huang, R.-Y., Repasky, E.A., Wang, X., and Li, F. (2018). An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer.J Exp Clin Cancer Res37, 240.
Mato, E., Gonzalez, C., Moral, A., Pérez, J.Ignacio, Bell, O., Lerma, E., and de Leiva, A. (2014). ABCG2/BCRP gene expression related with EMT inducer genes in papillary thyroid carcinoma.J Mol Endocrinol.
Marriott, S., Baskir, R.S., Gaskill, C., Menon, S., Carrier, E.J., Williams, J., Talati, M., Helm, K., Alford, C.E., Kropski, J.A., et al. (2014). ABCG2pos Lung Mesenchymal Stem Cells are a Novel Pericyte Subpopulation that Contributes to Fibrotic Remodeling.Am J Physiol Cell Physiol.
Czornyj, L., and Lazarowski, A. (2014). ABC-transporters as stem-cell markers in brain dysplasia/tumor epilepsies.Front Biosci (Landmark Ed)19, 1425-1435.
Chen, S., Yi, M., Zhou, G., Pu, Y., Hu, Y., Han, M., and Jin, H. (2019). Abdominal Aortic Transplantation of Bone Marrow Mesenchymal Stem Cells Regulates the Expression of Ciliary Neurotrophic Factor and Inflammatory Cytokines in a Rat Model of Spinal Cord Ischemia-Reperfusion Injury.Med Sci Monit25, 1960-1969.
Murphy, A.J., Pierce, J., de Caestecker, C., Libes, J., Neblett, D., de Caestecker, M., Perantoni, A.O., Tanigawa, S., Anderson, J.R., Dome, J.S., et al. (2013). Aberrant activation, nuclear localization, and phosphorylation of yes-associated protein-1 in the embryonic kidney and Wilms tumor.Pediatr Blood Cancer.
Lindblad, O., Cordero, E., Puissant, A., Macaulay, L., Ramos, A., Kabir, N.N., Sun, J., Vallon-Christersson, J., Haraldsson, K., Hemann, M.T., et al. (2016). Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML.Oncogene.
Mizuno, G.O., Wang, Y., Shi, G., Wang, Y., Sun, J., Papadopoulos, S., Broussard, G.J., Unger, E.K., Deng, W., Weick, J., et al. (2018). Aberrant Calcium Signaling in Astrocytes Inhibits Neuronal Excitability in a Human Down Syndrome Stem Cell Model.Cell Rep24, 355-365.
Kawano, H., Ito, Y., Kanai, F., Nakamura, E., Tada, N., Takai, S., Horie, S., Kobayashi, T., and Hino, O. (2015). Aberrant differentiation of Tsc2-deficient teratomas associated with activation of the mTORC1-TFE3 pathway.Oncol Rep.
Liu, C.-H., Chou, C.-T., Chen, C.-H., Chen, C.-H., Yang, S.-Y., Ko, Y.-A., Wu, Y.-T., Wang, C.-C., Liu, F.-C., Yue, C.-T., et al. (2020). Aberrant distribution and function of plasmacytoid dendritic cells in patients with ankylosing spondylitis are associated with unfolded protein response.Kaohsiung J Med Sci.
Sriraksa, R., Zeller, C., Dai, W., Siddiq, A., Walley, A.J., Limpaiboon, T., and Brown, R. (2013). Aberrant DNA methylation at genes associated with a stem cell-like phenotype in cholangiocarcinoma tumours.Cancer Prev Res (Phila).
Sakaguchi, H., Muramatsu, H., Okuno, Y., Makishima, H., Xu, Y., Furukawa-Hibi, Y., Wang, X., Narita, A., Yoshida, K., Shiraishi, Y., et al. (2015). Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia.Plos One10, e0145394.
Tesarova, L., Simara, P., Stejskal, S., and Koutna, I. (2016). The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture.Plos One11, e0157974.
Planello, A.C., Ji, J., Sharma, V., Singhania, R., Mbabaali, F., Müller, F., Alfaro, J.A., Bock, C., De Carvalho, D.D., and Batada, N.N. (2014). Aberrant DNA methylation reprogramming during induced pluripotent stem cell generation is dependent on the choice of reprogramming factors.Cell Regen (Lond)3, 4.
Xiong, L., Wu, F., Wu, Q., Xu, L., Cheung, O.K., Kang, W., Mok, M.T., Szeto, L.L.M., Lun, C.-Y., Lung, R.W., et al. (2019). Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming.Nat Commun10, 335.
Davis, H., Irshad, S., Bansal, M., Rafferty, H., Boitsova, T., Bardella, C., Jaeger, E., Lewis, A., Freeman-Mills, L., Giner, F.C., et al. (2014). Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche.Nat Med.